Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$651M |
| 2 |
Fidelity Wise Origin Bitcoin Fund
FBTC
|
+$622M |
| 3 |
Merck
MRK
|
+$496M |
| 4 |
Adobe
ADBE
|
+$446M |
| 5 |
CRH
CRH
|
+$410M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.33B |
| 2 |
Microsoft
MSFT
|
+$965M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$542M |
| 4 |
NVIDIA
NVDA
|
+$522M |
| 5 |
Linde
LIN
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.55% |
| 2 | Healthcare | 6.96% |
| 3 | Financials | 6.02% |
| 4 | Industrials | 5.05% |
| 5 | Consumer Discretionary | 4.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Werner Enterprises
WERN
$2.29B
| $2.8M | ﹤0.01% |
71,545
-239,772
| -77% | -$9.56M |
|
3327
PUT
Lantheus
LNTH
$6.59B
| $2.79M | ﹤0.01% |
44,900
+24,700
| +122% | +$1.45M |
|
3328
Nektar Therapeutics
NKTR
$2.47B
| $2.79M | ﹤0.01% |
198,970
+92,560
| +87% | +$969K |
|
3329
Astronics
ATRO
$3.76B
| $2.79M | ﹤0.01% |
175,668
-242,790
| -58% | -$3.61M |
|
3330
Ardmore Shipping
ASC
$692M
| $2.79M | ﹤0.01% |
169,710
+154,805
| +1,039% | +$2.46M |
|
3331
Telefônica Brasil
VIV
$19.9B
| $2.78M | ﹤0.01% |
276,367
+44,290
| +19% | +$466K |
|
3332
Smith-Midland
SMID
$148M
| $2.78M | ﹤0.01% |
59,233
+43,610
| +279% | +$1.78M |
|
|
MRSH
3333
PUT
Marsh
MRSH
$90.5B
| $2.78M | ﹤0.01% |
13,500
-7,100
| -34% | -$1.42M |
|
3334
Invesco S&P 500 Low Volatility ETF
SPLV
$7.22B
| $2.78M | ﹤0.01% |
42,205
+34,919
| +479% | +$2.23M |
|
3335
Criteo S.A. Ordinary Shares
CRTO
$1.12B
| $2.78M | ﹤0.01% |
79,128
-450,992
| -85% | -$13.5M |
|
3336
PUT
Northern Trust
NTRS
$33.5B
| $2.77M | ﹤0.01% |
+31,200
| New | +$2.56M |
|
3337
Rigel Pharmaceuticals
RIGL
$725M
| $2.77M | ﹤0.01% |
187,299
+109,715
| +141% | +$1.48M |
|
3338
Deutsche Bank
DB
$70.7B
| $2.77M | ﹤0.01% |
175,730
+113,302
| +181% | +$1.55M |
|
3339
Black Diamond Therapeutics
BDTX
$101M
| $2.77M | ﹤0.01% |
546,237
+424,428
| +348% | +$1.71M |
|
3340
Twin Disc
TWIN
$345M
| $2.76M | ﹤0.01% |
166,957
+106,434
| +176% | +$1.67M |
|
3341
PUT
BioMarin Pharmaceuticals
BMRN
$11.7B
| $2.75M | ﹤0.01% |
31,500
-31,500
| -50% | -$2.82M |
|
3342
Sensient Technologies
SXT
$5.46B
| $2.75M | ﹤0.01% |
39,719
-14,214
| -26% | -$922K |
|
3343
Vanguard FTSE Emerging Markets ETF
VWO
$123B
| $2.75M | ﹤0.01% |
65,734
-46,589
| -41% | -$1.9M |
|
|
GAP
3344
PUT
The Gap Inc
GAP
$7.48B
| $2.74M | ﹤0.01% |
99,600
-435,000
| -81% | -$9.17M |
|
3345
PagerDuty
PD
$858M
| $2.74M | ﹤0.01% |
120,790
-288,996
| -71% | -$6.86M |
|
|
3346
CALL
Northern Trust
NTRS
$33.5B
| $2.74M | ﹤0.01% |
+30,800
| New | +$2.53M |
|
|
SBXC.U
3347
DELISTED
SilverBox Corp III Units, each consisting of one Class A Common Stock and one-third of one redeemable warrant
SBXC.U
| $2.74M | ﹤0.01% |
250,000
| – | – |
|
|
CGC
3348
Canopy Growth
CGC
$393M
| $2.74M | ﹤0.01% |
317,373
+228,110
| +256% | +$984K |
|
3349
CALL
Antero Resources
AR
$11B
| $2.73M | ﹤0.01% |
94,200
-1,226,500
| -93% | -$29.6M |
|
3350
CALL
Okta
OKTA
$25.6B
| $2.73M | ﹤0.01% |
26,100
+18,900
| +263% | +$1.74M |
|
Similar funds
Millennium Management's Q1 2024 Portfolio in Review
As of Q1 2024, Millennium Management held 6,887 positions worth $234B, up 1.3% from $231B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Millennium Management withdrew a net $25.1B in Q1 2024, closing 745 positions and reducing 2,484 holdings. Its most notable exit was Splunk Inc, an estimated $319M position sold in full.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 8.3% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Millennium Management opened a new position in iShares Bitcoin Trust worth $844M.
- Millennium Management's largest Q1 2024 buy was iShares Bitcoin Trust: 20,859,447 shares worth $844M.
- Millennium Management added most to Merck in Q1 2024, an estimated $496M increase.
- Millennium Management's biggest Q1 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $4.33B.
- Millennium Management fully exited Splunk Inc in Q1 2024, selling an estimated $319M.
- Millennium Management's ten largest holdings make up 17% of its $234B portfolio in Q1 2024.
- Millennium Management opened 858 new positions and closed 745 in Q1 2024.
- Millennium Management's portfolio value rose 1.3% quarter-over-quarter to $234B.
Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.